evaluate the digital health company amwell on wegovy / semaglutide Wegovy® Online — Brand-Name Doctors Petition FDA for Labeling

The STEP 5 trial provided 104-week data showing sustained efficacy

It works by: Enhancing insulin secretion in a glucose-dependent manner, which helps lower blood sugar without causing hypoglycemia when used alone Suppressing glucagon release from the pancreas, reducing hepatic glucose production Slowing gastric emptying , which prolongs satiety and reduces appetite Acting on central appetite centers in the hypothalamus to decrease food intake Semaglutide is administered subcutaneously (Ozempic, Wegovy) or orally (Rybelsus) and is primarily eliminated via proteolytic degradation, not through hepatic cytochrome P450 enzymes

Retatrutide is a GLP-1/GIP/glucagon triple agonist originally developed for obesity treatment

Its easy to fall into the trap of oversimplifying nutrition on GLP-1